3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Breast Neoplasms
33
Pain, Postoperative
4
Chronic Pain
3
Neoplasms
2
Lymphoma, Non-Hodgkin
2
Lung Neoplasms
2
Breast Diseases
2
Brain Neoplasms
2
Agnosia
2
Vulvodynia
1
Uterine Cervical Neoplasms
1
Skin Diseases
1
Seroma
1
Recurrence
1
Radiation Injuries
1
Postoperative Hemorrhage
1
Peripheral Nervous System Diseases
1
Pathologic Complete Response
1
Ovarian Neoplasms
1
Neoplasms by Site
1
Mycosis Fungoides
1
Melanoma
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, B-Cell, Marginal Zone
1
Hot Flashes
1
Hodgkin Disease
1
Head and Neck Neoplasms
1
Gastrointestinal Neoplasms
1
Gangliosidosis, GM1
1
Gangliosidoses
1
Interventions
Cyclophosphamide
6
Radiotherapy
5
olaparib
3
exemestane
3
Paclitaxel
3
Letrozole
3
Itraconazole
3
Gemcitabine
3
Fulvestrant
3
Carboplatin
3
Blood Specimen Collection
3
palbociclib
2
fludarabine phosphate
2
eribulin
2
avelumab
2
abemaciclib
2
Therapeutics
2
Polymerase Chain Reaction
2
Peripheral Blood Stem Cell Transplantation
2
Melphalan
2
Mastectomy
2
Flow Cytometry
2
Filgrastim
2
Exercise
2
Everolimus
2
Etoposide
2
Dasatinib
2
Cetuximab
2
Carmustine
2
Bevacizumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recurrence
×
Sodium Chloride
×
Breast
×
Clear all
NCT00925548
2014-07-24
STRIDE
EMD Serono
Phase 3
Terminated
16 enrolled
6 charts